Atrasentan hydrochloride 10mg

Atrasentan hydrochloride is an endothelin antagonist receptor (IC50=0.0551 nM, ETA) being developed for the treatment of prostate cancer.

Trivial name Atrasentan hydrochloride 10mg
Catalog Number A15007-10
Alternative Name(s) (2R,3R,4S)-4-(1,3-benzodioxol-5-yl)-1-[2-(dibutylamino)-2-oxoethyl]-2-(4-methoxyphenyl)pyrrolidine-3-carboxylic acid,hydrochloride
Molecular Formula C29H39ClN2O6
CAS# 195733-43-8
SMILES CCCCN(CCCC)C(=O)CN1CC(C(C1C2=CC=C(C=C2)OC)C(=O)O)C3=CC4=C(C=C3)OCO4.Cl
Size 10mg
Supplier Page http://www.adooq.com/atrasentan-hydrochloride.html